跳至主要内容
临床试验/ITMCTR2000002911
ITMCTR2000002911尚未招募1 期

Clinical Study for the Treatment of Pelvic Organ Prolapse by Integrated Traditional Chinese and Western Medicine

The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
50 至 70(—)
性别
Female

入选标准

  • (1) Women aged 50-70 years.
  • (2) There is no neuromuscular disease caused by other factors, and cognitive ability is normal.
  • (3) Meet the diagnostic criteria for pelvic organ prolapse I and II;
  • (4) Comply with the syndrome differentiation criteria of Yin Ting Qi Deficiency;
  • (5) No history of hormone use in the past 3 months;
  • (6) Informed consent and cooperation with inspection and treatment.

排除标准

  • (1) History of symptoms such as urination, chronic bronchitis, and urogenital infections.
  • (2) Previous history of pelvic surgery or transvaginal surgery.
  • (3) Malignant lesions of the reproductive system or diseases that can cause abnormal vaginal secretions (such as cervical cancer, endometrial cancer, fallopian tube cancer, CIN II or above, and acute pelvic inflammatory disease, etc.).
  • (4) Patients with severe diseases such as cardiovascular, liver, kidney and hematopoietic system or mental illness.(5) Patients with vaginal wall cysts.
  • (6) Patients who fail to treat as required, cannot judge the efficacy or have incomplete data, etc., which affect the effect observation.

研究者

发起方
The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine

相似试验